Phase I study using weekly Taxol (T) and gemcitabine (G) in patients with advanced non small cell lung cancer (NSCLC)

被引:0
|
作者
De Pas, T
De Braud, F
Sessa, C
Nole, F
Minchella, I
Catania, C
Goldhirsch, A
机构
[1] EIO, Milano, Italy
[2] HS Giovanni, Bellinzona, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
375
引用
收藏
页码:98 / 99
页数:2
相关论文
共 50 条
  • [41] A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients
    Giaccone, G
    Smit, EF
    van Meerbeeck, JP
    Splinter, T
    Golding, RP
    Pinedo, HM
    Laan, D
    van Tinteren, H
    Postmus, PE
    ANNALS OF ONCOLOGY, 2000, 11 (01) : 109 - 112
  • [42] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [43] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    LUNG CANCER, 2001, 33 (01) : 69 - 73
  • [44] Combination phase I study of neclaplatin and gemcitabine for advanced non-small-cell lung cancer
    Kurata, T
    Tamura, K
    Yamamoto, N
    Nogami, T
    Satoh, T
    Kaneda, H
    Nakagawa, K
    Fukuoka, M
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2092 - 2096
  • [45] Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer
    T Kurata
    K Tamura
    N Yamamoto
    T Nogami
    T Satoh
    H Kaneda
    K Nakagawa
    M Fukuoka
    British Journal of Cancer, 2004, 90 : 2092 - 2096
  • [46] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [47] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [48] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
  • [49] Preliminary results of a multicentre phase II study with gemcitabine monotherapy in the elderly patients with advanced non small cell lung cancer (NSCLC)
    Tibaldi, C
    Ricci, S
    Bonifazi, F
    Fioretto, ML
    Bertuccelli, M
    Petruzzelli, S
    Galli, L
    Antonuzzo, A
    Andrei, A
    Tavanti, L
    Giallombardo, A
    Chiavacci, A
    Pegna, AL
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 83 - 83
  • [50] Phase (Ph) I/II study of pembrolizumab (P) with gemcitabine (G) in patients (pts) with previously-treated advanced (Adv) non-small cell lung cancer (NSCLC).
    Sanborn, Rachel E.
    Duffy, Regan M.
    Fisher, Brenda K.
    Perlewitz, Kelly Shea
    Wallen, Herschel D.
    Li, Rui
    Redmond, William L.
    Koguchi, Yoshinobu
    Fox, Bernard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)